{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:25Z","timestamp":1792794925417,"version":"4.5.0"},"reference-count":41,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.1080\/14740338.2024.2392865","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:10:40Z","timestamp":1723612240000},"page":"949-957","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Systematic analysis of the adverse effects of commonly used clinical tetracycline drugs based on the FAERS database"],"prefix":"10.1080","volume":"24","author":[{"given":"Chun-Yan","family":"Xiong","sequence":"first","affiliation":[{"name":"the First People\u2019s Hospital of Zhaotong","place":["Zhaotong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Min","family":"Yang","sequence":"additional","affiliation":[{"name":"Kunming Kingmed Institute for Clinical Laboratory Co. Ltd","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"the First People\u2019s Hospital of Zhaotong","place":["Zhaotong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Shu","family":"He","sequence":"additional","affiliation":[{"name":"the First People\u2019s Hospital of Zhaotong","place":["Zhaotong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Wei","family":"Luo","sequence":"additional","affiliation":[{"name":"the First People\u2019s Hospital of Zhaotong","place":["Zhaotong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[{"name":"the First People\u2019s Hospital of Zhaotong","place":["Zhaotong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Xue","family":"Mao","sequence":"additional","affiliation":[{"name":"Kunming Kingmed Institute for Clinical Laboratory Co. Ltd","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025387"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2019-0199"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874467214666210210122628"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04121-1"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01257-4"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0545-8"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-022-01397-5"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2020.100148"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00901-7"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-022-00369-z"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.931"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040826"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1742"},{"key":"e_1_3_7_15_1","unstructured":"DOXY 100(TM) DOXYCYCLINE- doxy 100(tm) doxycycline injection powder lyophilized for solution HF acquisition Co LLC DBA HealthFirst. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=062475"},{"key":"e_1_3_7_16_1","unstructured":"DOXYCYCLINE- doxycycline capsule REMEDYREPACK INC. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=204234"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/ONO.0000000000000043"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652674"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.603"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joto.2016.10.001"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.4.515"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15769"},{"key":"e_1_3_7_23_1","unstructured":"MINOCYCLINE HYDROCHLORIDE- minocycline hydrochloride tablet film coated extended release. Bryant Ranch Prepack. Available from:https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=204453"},{"key":"e_1_3_7_24_1","unstructured":"MINOCIN- minocycline hydrochloride injection melinta therapeutics LLC. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=050444"},{"key":"e_1_3_7_25_1","unstructured":"AMZEEQ- minocycline aerosol foam journey medical corporation. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=212379"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20590"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1996.6.211"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7944(01)00476-7"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2020.08.028"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21656"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.21037\/gs-22-482"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/014556131409310-1110"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcac113"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000502843"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2015.08.009"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c18-00844"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00912-5"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800201"},{"key":"e_1_3_7_39_1","unstructured":"NUZYRA- omadacycline injection powder lyophilized for solution NUZYRA- omadacycline tablet film coated. Paratek Pharmaceuticals Inc. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=209816"},{"issue":"11","key":"e_1_3_7_40_1","first-page":"E53","article-title":"Safety and tolerability of Sarecycline for the treatment of acne vulgaris: results from a phase III, multicenter, open-label study and a phase I phototoxicity study","volume":"12","author":"Pariser DM","year":"2019","unstructured":"Pariser DM, Green LJ, Lain EL, et al. Safety and tolerability of Sarecycline for the treatment of acne vulgaris: results from a phase III, multicenter, open-label study and a phase I phototoxicity study. J Clin Aesthet Dermatol. 2019 Nov;12(11):E53\u2013E62.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_7_41_1","unstructured":"SEYSARA- Sarecycline hydrochloride tablet coated Almirall LLC. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=209521"},{"key":"e_1_3_7_42_1","unstructured":"XERAVA- Eravacycline injection powder lyophilized for solution. Tetraphase Pharmaceuticals Inc. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=211109"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2392865","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:16:47Z","timestamp":1776932207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2392865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,3]]}},"alternative-id":["10.1080\/14740338.2024.2392865"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2392865","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}